Literature DB >> 31226102

Congenital myasthenic syndrome due to rapsyn deficiency: A case report with a new mutation and compound heterozygosity.

Ivan O Espinoza1, Carolina Reynoso2, Giulliana Chávez3, Andrew G Engel4.   

Abstract

INTRODUCTION: The congenital myasthenic syndromes are a heterogeneous group of genetic disorders characterized by an abnormal synaptic transmission in the neuromuscular plate. REPORT: We present a two-year-old patient, male, with hypotonia, palpebral ptosis, and proximal symmetric weakness with a neonatal onset that motivated several and prolonged hospitalizations for pneumonia and respiratory failure. From two years of age, the parents noticed that the facial and general weakness worsened in the afternoons and with repeated or prolonged physical activity. The physical examination showed palpebral ptosis, predominantly proximal weakness, and fatigability with sustained muscular effort. The electromyography showed a 27% decrement in the Compound Muscular Action Potential and the case-parents genetic study showed compound heterozygosity with the transmission of two different mutations in the rapsyn gene from both parents. The patient received pyridostigmine with great improvement, achieving optimal performance in school, sports, and daily life activities.
CONCLUSIONS: Weakness and fatigability with neonatal onset, mainly affecting the muscles with brain stem innervation and the decrement greater than 10 percent in the Compound Muscular Action Potential in the electromyographic studies, should make us suspect in a congenital myasthenic syndrome. We review the literature and key clinical points to establish a timely diagnosis and effective treatment in some of these syndromes.

Entities:  

Keywords:  missense mutation; muscle proteins; myasthenia gravis; neuromuscular junction diseases; congenital myasthenic syndromes

Mesh:

Substances:

Year:  2019        PMID: 31226102      PMCID: PMC6655474          DOI: 10.5867/medwave.2019.05.7645

Source DB:  PubMed          Journal:  Medwave        ISSN: 0717-6384


  10 in total

1.  Structure and superorganization of acetylcholine receptor-rapsyn complexes.

Authors:  Benoît Zuber; Nigel Unwin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

Review 2.  Congenital myasthenic syndromes: an update.

Authors:  Daniel Hantaï; Sophie Nicole; Bruno Eymard
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

Review 3.  Clinical and genetic basis of congenital myasthenic syndromes.

Authors:  Paulo Victor Sgobbi de Souza; Gabriel Novaes de Rezende Batistella; Valéria Cavalcante Lino; Wladimir Bocca Vieira de Rezende Pinto; Marcelo Annes; Acary Souza Bulle Oliveira
Journal:  Arq Neuropsiquiatr       Date:  2016-09       Impact factor: 1.420

Review 4.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

5.  Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.

Authors:  M Milone; X M Shen; D Selcen; K Ohno; J Brengman; S T Iannaccone; C M Harper; A G Engel
Journal:  Neurology       Date:  2009-07-21       Impact factor: 9.910

6.  Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.

Authors:  J S Müller; G Mildner; W Müller-Felber; U Schara; K Krampfl; B Petersen; S Petrova; R Stucka; W Mortier; J Bufler; G Kurlemann; A Huebner; L Merlini; H Lochmüller; A Abicht
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

7.  E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome.

Authors:  Kinji Ohno; Menachem Sadeh; Ilan Blatt; Joan M Brengman; Andrew G Engel
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

8.  Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.

Authors:  D Natera-de Benito; M Bestué; J J Vilchez; T Evangelista; A Töpf; A García-Ribes; M J Trujillo-Tiebas; M García-Hoyos; C Ortez; A Camacho; E Jiménez; M Dusl; A Abicht; H Lochmüller; J Colomer; A Nascimento
Journal:  Neuromuscul Disord       Date:  2015-11-23       Impact factor: 4.296

9.  Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.

Authors:  Judy Cossins; Georgina Burke; Susan Maxwell; Hayley Spearman; Somai Man; Jan Kuks; Angela Vincent; Jackie Palace; Christian Fuhrer; David Beeson
Journal:  Brain       Date:  2006-08-31       Impact factor: 13.501

Review 10.  Congenital myasthenic syndromes and the neuromuscular junction.

Authors:  Pedro M Rodríguez Cruz; Jacqueline Palace; David Beeson
Journal:  Curr Opin Neurol       Date:  2014-10       Impact factor: 5.710

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.